Literature DB >> 11514705

18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

G Laking1, P Price.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514705      PMCID: PMC1765989     

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  54 in total

1.  Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.

Authors:  E Weng; L Tran; S Rege; A Safa; A Sadeghi; G Juillard; R Mark; S Santiago; C Brown; M Mandelkern
Journal:  Am J Clin Oncol       Date:  2000-02       Impact factor: 2.339

2.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

3.  Modern thirty-day operative mortality for surgical resections in lung cancer.

Authors:  R J Ginsberg; L D Hill; R T Eagan; P Thomas; C F Mountain; J Deslauriers; W A Fry; R O Butz; M Goldberg; P F Waters
Journal:  J Thorac Cardiovasc Surg       Date:  1983-11       Impact factor: 5.209

4.  Staging non-small cell lung cancer by whole-body positron emission tomographic imaging.

Authors:  P E Valk; T R Pounds; D M Hopkins; M K Haseman; G A Hofer; H B Greiss; R W Myers; C L Lutrin
Journal:  Ann Thorac Surg       Date:  1995-12       Impact factor: 4.330

5.  Overview on small cell lung cancer in the world: industrialized countries, Third World, eastern Europe.

Authors:  D M Parkin; R Sankaranarayanan
Journal:  Anticancer Res       Date:  1994 Jan-Feb       Impact factor: 2.480

6.  Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cancer.

Authors:  Y Watanabe; J Shimizu; M Tsubota; T Iwa
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

7.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

Authors:  G Di Chiro; R L DeLaPaz; R A Brooks; L Sokoloff; P L Kornblith; B H Smith; N J Patronas; C V Kufta; R M Kessler; G S Johnston; R G Manning; A P Wolf
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

8.  Mediastinal staging of non-small-cell lung cancer with positron emission tomography.

Authors:  R Chin; R Ward; J W Keyes; R H Choplin; J C Reed; S Wallenhaupt; A S Hudspeth; E F Haponik
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

9.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

Authors:  R L Wahl; L E Quint; R L Greenough; C R Meyer; R I White; M B Orringer
Journal:  Radiology       Date:  1994-05       Impact factor: 11.105

10.  Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.

Authors:  E F Patz; V J Lowe; P C Goodman; J Herndon
Journal:  Chest       Date:  1995-12       Impact factor: 9.410

View more
  3 in total

1.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 2.  Neuroimaging Methods for Nursing Science.

Authors:  Sebastian W Atalla; Laura Beth Kalvas; Jenna L Campbell; Alison R Anderson; Ronald L Cowan; Kathy Wright; Angela C Humbel; Todd B Monroe
Journal:  Nurs Res       Date:  2020 May/Jun       Impact factor: 2.381

3.  Lonidamine: basic science and rationale for treatment of prostatic proliferative disorders.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2005
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.